Imiquimod
Y. Vivian Tsai, Pharm.D., Kathryn Dzintars, Pharm.D., BCPS
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Actinic keratosis on the face or scalp (including typical, nonhyperkeratotic, nonhypertrophic) in immunocompetent adults
- Superficial basal cell carcinoma in immunocompetent adults
- Biopsy-confirmed primary superficial BCC, maximum diameter 2 cm, trunk (excluding anogenital skin), neck, or extremities (excluding hands/feet), in immunocompetent adults, only when surgery is medically less appropriate and reliable follow-up is possible.
- External genital and perianal warts in immunocompetent patients ≥12 years old
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Vulvar high-grade squamous intraepithelial lesion (vHSIL; usual-type VIN)
- Genital HSV infection, acyclovir-resistant
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2026 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.